Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice

  1. Shrestha Ghosh
  2. Sheung Kin Wong
  3. Zhixin Jiang
  4. Baohua Liu
  5. Yi Wang
  6. Quan Hao
  7. Vera Gorbunova
  8. Xinguang Liu
  9. Zhongjun Zhou  Is a corresponding author
  1. The University of Hong Kong, Hong Kong
  2. Shenzhen University, China
  3. University of Rochester, United States
  4. Guangdong Medical University, China
6 figures and 1 additional file

Figures

Figure 1 with 1 supplement
Heterozygosity of Trp53 rescues premature senescence in Sirt6-deficient scenario, (Trp53 has been denoted as p53 in the figures).

(A) Quantification for qPCR analyses for gene expression of p53 targets (with respect to Gapdh controls) in Sirt6+/+Trp53+/+ (WT) and Sirt6-/-Trp53+/+ (Sirt6 KO) MEFs, respectively. Data represent …

https://doi.org/10.7554/eLife.32127.003
Figure 1—figure supplement 1
Attenuation of p53 downstream targets and rescue of premature senescence-associated phenotypes in Sirt6-deficient scenario by haploinsufficiency of Trp53, (Trp53 has been denoted as p53 in the figures).

(A) Representative images of MEFs derived from Sirt6+/+Trp53+/+, Sirt6-/-Trp53+/+ and Sirt6-/-Trp53+/- embryos at P6. Scale bar, 100 µm. (B) qPCR analyses of p53 mRNA levels in Sirt6+/+Trp53+/+, …

https://doi.org/10.7554/eLife.32127.004
Figure 2 with 1 supplement
Haploinsufficiency of Trp53 significantly extends the lifespan of Sirt6-deficient mice, (Trp53 has been denoted as p53 in the figures).

(A) Representative images of Sirt6+/+Trp53+/+(WT), Sirt6-/-Trp53+/+ (Sirt6 KO), and -/-Trp53+/- (compound mutant) littermate mice at the age of 24 days. (B) Mean body weights of WT, Sirt6 KO and …

https://doi.org/10.7554/eLife.32127.005
Figure 2—source data 1

Serum Igf-1 levels in 24-day old mice.

https://doi.org/10.7554/eLife.32127.007
Figure 2—source data 2

Serum Igf-1 levels in 10-16 months old mice.

https://doi.org/10.7554/eLife.32127.008
Figure 2—source data 3

Serum glucose levels in 24-day old mice.

https://doi.org/10.7554/eLife.32127.009
Figure 2—source data 4

Serum glucose levels in 10-16 months old mice.

https://doi.org/10.7554/eLife.32127.010
Figure 2—figure supplement 1
Analysis of serum IGF-1 and glucose levels in Sirt6+/+Trp53+/+, Sirt6-/-Trp53+/+ and Sirt6-/-Trp53+/- mice, (Trp53 has been denoted as p53 in the figures).

(A) Serum IGF-1 levels in Sirt6+/+Trp53+/+, Sirt6-/-Trp53+/+ and Sirt6-/-Trp53+/- mice at around 24 days. P value calculated using one-way ANOVA. (B) Serum IGF-1 levels in Sirt6+/+Trp53+/+ and Sirt6-…

https://doi.org/10.7554/eLife.32127.006
Figure 3 with 1 supplement
Amelioration of premature-aging associated phenotypes in Sirt6 KO mice upon haploinsufficiency of p53, (Trp53 has been denoted as p53 in the figures).

(A) Representative images of spleens, thymus, livers, kidneys, lungs and hearts from 24 days old Sirt6+/+Trp53+/+, Sirt6-/-Trp53+/+, and Sirt6-/-Trp53+/- mice. (B) Whole body X-ray images of female …

https://doi.org/10.7554/eLife.32127.011
Figure 3—figure supplement 1
Incidence of cancer and other age-associated disorders in Sirt6-/-Trp53+/- mice, (Trp53 has been denoted as p53 in the figures).

(A) Whole body X-ray images of female and male Sirt6+/+Trp53+/+, Sirt6-/-Trp53+/+ and Sirt6-/-Trp53+/- mice (note the lordokyphosis/curved spine in Sirt6-/-Trp53+/+ mice) at the age of 24 days. (B) …

https://doi.org/10.7554/eLife.32127.012
Haploinsufficiency of Trp53 prevents bone marrow stem cell decline, suppresses apoptosis, and restores immune cell populations in Sirt6-deficient mice, (Trp53 has been denoted as p53 in the figures).

(A) Percentage of mesenchymal stem cell (MSC) population in the female Sirt6+/+Trp53+/+, Sirt6-/-Trp53+/+ and Sirt6-/-Trp53+/- mice at the age of ~24 days. Data represent mean ± SEM; n=5. (B) …

https://doi.org/10.7554/eLife.32127.013
Figure 5 with 1 supplement
SIRT6 directly deacetylates p53 at lysine 381, but not K382.

(A) Western blotting analysis of endogenous interaction between SIRT6 and p53 in mock CRISPR control cells and SIRT6 KO cells using specific antibodies for SIRT6 and p53, keeping respective IgG …

https://doi.org/10.7554/eLife.32127.014
Figure 5—figure supplement 1
Analyses of physical and functional interaction between SIRT6 and p53, (Trp53 has been denoted as p53 in the figures).

(A) Western blotting analysis of endogenous p53 pulled down by FLAG-tagged SIRT6 in HEK293 cells. (B) Western blotting analysis of endogenous SIRT6 pulled down by FLAG-tagged p53 in HEK293 cells. (C)…

https://doi.org/10.7554/eLife.32127.015
Figure 6 with 2 supplements
SIRT6 negatively regulates the stability of p53.

(A) Western blotting analysis of p53 protein expression in SIRT6 KO and control HEK293 cells. (B) Quantification of data presented in (A). Data represent mean ± SEM, n = 3. **p<0.01 calculated using …

https://doi.org/10.7554/eLife.32127.016
Figure 6—figure supplement 1
Analyses of the stability of p53 in the presence and absence of SIRT6.

(A) Western blotting analysis of p53 protein expression in Sirt6+/+ and Sirt6-/- MEFs. (B) Immunofluorescence staining to confirm enhanced p53 protein expression in WT and Sirt6-/- MEFs. Scale bar, …

https://doi.org/10.7554/eLife.32127.017
Figure 6—figure supplement 2
Acetyl mimic mutant p53 K381Q confers stability to p53 and imparts senescence-like properties to cells.

(A) FLAG-tagged p53 wild-type (WT), lysine 381 to arginine (K381R, non-acetylatable) mutant, and lysine 381 to glutamine (K381Q, acetyl-mimic) mutants were ectopically expressed in HEK293 cells. …

https://doi.org/10.7554/eLife.32127.018

Additional files

Download links